Login / Signup

Parenclitic network mapping identifies response to targeted albumin therapy in patients hospitalized with decompensated cirrhosis.

Tope OyeladeEwan ForrestKevin P MooreAlastair O'BrienAlireza Mani
Published in: Clinical and translational gastroenterology (2023)
The parenclitic network mapping can predict survival of patients with cirrhosis and identify patient subgroups that don't benefit from targeted albumin therapy.
Keyphrases
  • high resolution
  • cancer therapy
  • heart failure
  • high density
  • case report
  • mass spectrometry
  • gene expression
  • bone marrow
  • liver failure
  • network analysis
  • cell therapy
  • atrial fibrillation
  • chemotherapy induced